Meet Fogarty Innovation
To better build on the values and opportunities inherent in the medical device community, this year Medtech Strategist’s Virtual Investment & Partnering Summit is joining with a leading player in the industry - Fogarty Innovation - to create a new kind of conference.
Fogarty Innovation
Meet the new Fogarty Innovation: A Message from Andrew Cleeland, CEO
I am happy to introduce a new chapter for Fogarty Innovation (formerly The Fogarty Institute for Innovation). We’ve recently undertaken an effort to re-envision ourselves to better address the needs of innovators in the evolving medtech landscape and are ready to share our new direction. While we will always be true to our historical roots as a medtech incubator, our unrivalled position as a non-profit in the startup world affords us the unique ability to bring disparate groups together that can have a positive impact on the global medtech innovation ecosystem. As such, we see ourselves more broadly as a global hub for novel thinking and creation — providing a bold model for shaping the future of human health. Visit our new website at https://www.fogartyinnovation.org/ to learn more.
We are honored to be co-organizing this virtual Investment and Partnering Summit with MedTech Strategist, New Enterprise Associates, WSGR, and Lightstone Ventures and will use this stage to share thought-provoking content with you. Fogarty Innovation staff will dive into timely topics with industry luminaries. These presentations and panels should be of interest to those involved with small to mid-sized medtech companies trying to steer through today’s uncertain environment.
Following are the discussions we have lined up for you. Check back periodically to learn the exact dates the sessions will be made available on the summit platform.
1. Charting the Course for Medtech: Exits and Investment Activity in 2020 and Expectations for 2021
A presentation by Jon Norris, Managing Director, Silicon Valley Bank Life Sciences, moderated by Andrew Cleeland, CEO, Fogarty Innovation
2. Funding the Medtech Startup Journey
(available October 26, 2020)
Panelists :
James Eadie MD, Partner, Sante Ventures
Susan Stimson, Executive in Residence, KCK Group
Cynthia Yee, Principal, Vensana Capital
Moderator: Mike Regan, Chief Innovation Officer, Fogarty Innovation
3. Weathering the Storm: The State of Innovation in a COVID World
(available October 26, 2020)
Panelists:
Harith Rajagopalan, Co-founder and CEO, Fractyl Laboratories
Gabriel Sanchez, CEO & Founder, Enspectra Health
Leslie Trigg, CEO, Outset Medical
Moderator: Greg Bakan, COO, Fogarty Innovation
4. Navigating the Call to Diversity
(available October 22, 2020)
Panelists:
Donna Collins, Senior Director Global Marketing, Stryker Neurovascular
Maria Sainz, CEO, Aegea Medical, Co-founder, Diversity by Doing Healthtech (DxD)
Kwame Ulmer, Venture Partner, Wavemaker Three-Sixty Health; Founder, Medtech Color; Principal, Ulmer Ventures
Moderator: Marga Ortigas-Wedekind, Chief Commercial Strategy Officer, Fogarty Innovation
5. Tales From the Voyage: A Fireside Chat with a Couple of Industry Veterans
A conversation about medtech innovation with Paul Yock, Founder and Director, Stanford Byers Center for Biodesign and Andrew Cleeland, CEO, Fogarty Innovation
6. An Innovative Tack at the FDA
A conversation between Doug Kelly, newly appointed Deputy Director for Science, CDRH, (former General Partner at Alloy Ventures) and Andrew Cleeland, CEO, Fogarty Innovation
